Free Trial

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.90 -0.05 (-5.26%)
As of 11:09 AM Eastern

KNB vs. TLY, SPI, MGP, SBI, AREC, AKR, AOR, RENX, STX, and OPTI

Should you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Arecor Therapeutics (AREC), Akers Biosciences (AKR), AorTech International (AOR), Renalytix (RENX), Shield Therapeutics (STX), and OptiBiotix Health (OPTI). These companies are all part of the "medical" sector.

Kanabo Group vs.

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.

Totally has a consensus target price of GBX 20, indicating a potential upside of 133.89%. Given Totally's stronger consensus rating and higher probable upside, analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Kanabo GroupN/AN/A
TotallyOutperform Votes
131
72.78%
Underperform Votes
49
27.22%

Kanabo Group has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled Totally'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Totally Neutral

Kanabo Group has a net margin of 0.00% compared to Totally's net margin of -2.94%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo GroupN/A -83.19% -20.89%
Totally -2.94%-8.85%-2.42%

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 51.3% of Totally shares are held by institutional investors. 37.0% of Kanabo Group shares are held by company insiders. Comparatively, 13.3% of Totally shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M4.99-£8.18M-£0.01-90.00
Totally£106.68M0.16-£3.13M-£0.02-427.55

Summary

Totally beats Kanabo Group on 9 of the 15 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£5.69M£1.51B£5.39B£2.04B
Dividend YieldN/A3.92%5.37%5.16%
P/E Ratio-90.00111.2988.261,926.65
Price / Sales4.9939.511,286.31384,006.48
Price / Cash1.8212.5136.6029.21
Price / Book0.902.154.953.08
Net Income-£8.18M£55.02M£117.96M£183.60M
7 Day PerformanceN/A-1.09%2.50%3.09%
1 Month Performance12.50%0.27%3.42%3.42%
1 Year Performance-60.87%8.08%27.15%165.41%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.90
-5.3%
N/A-60.9%£5.69M£1.14M-90.0020Gap Down
TLY
Totally
N/AGBX 9.25
flat
GBX 20
+116.2%
+95.8%£18.18M£106.68M-462.501,668Gap Up
High Trading Volume
SPI
Spire Healthcare Group
2.7986 of 5 stars
GBX 228
+0.9%
GBX 322
+41.2%
+4.4%£920.71M£1.44B3,257.14420News Coverage
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
AREC
Arecor Therapeutics
N/AGBX 59.40
+1.5%
N/A-65.8%£22.43M£4.90M-212.1410
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
AOR
AorTech International
N/AN/AN/AN/A£19.99M£539,000.00-33.383
RENX
Renalytix
N/AGBX 11.56
-3.7%
N/A+2.2%£19.17M£2.29M-48.15102
STX
Shield Therapeutics
N/AGBX 2.30
-2.1%
N/A-65.7%£17.99M£21.47M-57.5040,000
OPTI
OptiBiotix Health
N/AGBX 17.37
-0.7%
N/A-30.1%£17.01M£1.26M-579.001News Coverage
Gap Up

Related Companies and Tools


This page (LON:KNB) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners